Showing results (301-310 of 401) with videos related to

Sort By:
Pageof 41
NPJ Precision Oncology|November 3, 2024
Driver mutations associated with signatures of platinum sensitivity in germ cell tumorsYun Cheng Sawa, Liwei Jia, Harris Krause, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell TumorsDarren R Feldman, James Hu, Tanya B Dorff, et al.
Cancer Causes & Control : CCC|June 14, 2022
Race reporting and disparities regarding clinical trials in bladder cancer: a systematic reviewElliott Freudenburg, Iyla Bagheri, Sunay Srinivas, et al.
World Journal of Urology|June 19, 2017
Dose dense MVAC prior to radical cystectomy: a real-world experienceHomayoun Zargar, Jay B Shah, Elisabeth E Fransen van de Putte, et al.
The Journal of Urology|August 6, 2013
Refining patient selection for neoadjuvant chemotherapy before radical cystectomyStephen H Culp, Rian J Dickstein, H Barton Grossman, et al.
Clinical Genitourinary Cancer|September 29, 2022
Development of a Pocket Nomogram to Predict Cancer and Disease Specific Survival After Radical Cystectomy For Bladder Cancer: The CRAB NomogramAntonio Cicione, Giuseppe Simone, Riccardo Lombardo, et al.
World Journal of Urology|January 27, 2019
SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancerJeffrey J Leow, Jens Bedke, Karim Chamie, et al.
Future Oncology (London, England)|May 24, 2022
Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trialSumanta K Pal, Diederik M Somford, Petros Grivas, et al.
JAMA Network Open|July 20, 2026
Immune-Enhancing Nutrition and Outcomes After Radical Cystectomy: A Randomized Clinical TrialJill M Hamilton-Reeves, Joseph M Unger, Jeffrey M Holzbeierlein, et al.
Pageof 41